FU
FORE US Bio Inc.
SEC filingBiotechnology · Philadelphia, PA
Amount raised$70.4Msold at filing
Total offering$109.6M$39.2M still open
Investors in the raise20count reported to the SEC
FiledJul 14, 2026first sale Apr 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
William HinshawExecutive Officer, Director
Michael ByrnesExecutive Officer
Giovanni MariggiDirector
Kim BlackwellDirector
Erez ChimovitsDirector
Rajeev DadooDirector
Dieter WeinandDirector
Chandra LeoDirector
Executive officers, directors and promoters as listed on the Form D.